Back
  1. Home
  2. Profile of Benjamin KOOPMANSCH (ULiège)
Profil

KOOPMANSCH Benjamin

Unilab > Unité de laboratoire - oncologie et hématologie

See author's contact details
Main Referenced Co-authors
Lambert, Frédéric  (12)
Bours, Vincent  (6)
Delvenne, Philippe  (5)
Peulen, Olivier  (4)
Bellahcene, Akeila  (3)
Main Referenced Keywords
Humans (2); KLF4 (2); 18F-FDG PET/CT (1); AKT signaling (1); aminoguanidine (1);
Main Referenced Unit & Research Centers
Giga-Cancer - ULiège (3)
GIGA‐R - Giga‐Research - ULiège (1)
Main Referenced Disciplines
Oncology (7)
Biochemistry, biophysics & molecular biology (7)
Genetics & genetic processes (3)
Hematology (2)
Endocrinology, metabolism & nutrition (1)

Publications (total 20)

The most downloaded
1644 downloads
JERUSALEM, G., COLLIGNON, J., Josse, C., SCHROEDER, H., RORIVE, A., FRERES, P., LAMBERT, F., KOOPMANSCH, B., PONCIN, A., & BOURS, V. (2015). Cancer du sein : de la thérapie ciblée à la médecine personnalisée. Revue Médicale de Liège, 70 (5-6), 269-276. https://hdl.handle.net/2268/184321

The most cited

150 citations (OpenAlex)

LOVINFOSSE, P., POLUS, M., VAN DAELE, D., Martinive, P., DAENEN, F., Hatt, M., Visvikis, D., KOOPMANSCH, B., LAMBERT, F., COIMBRA MARQUES, C., SEIDEL, L., Albert, A., Delvenne, P., & Hustinx, R. (2018). FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-017-3855-5 https://hdl.handle.net/2268/216166

Nokin, M.-J., Darbo, E., Richard, E., San José, S., de Hita, S., Prouzet-Mauleon, Turcs, B., Gerardelli, L., Crake, R., Velasco, V., KOOPMANSCH, B., Lambert, F., Xue, J. Y., Sang, B., Horne, J., Ziemons, E., Villanueva, A., Blomme, A., Herfs, M., ... Santamaria, D. (2024). In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma. Cell Reports Medicine. doi:10.1016/j.xcrm.2024.101663
Peer Reviewed verified by ORBi

Crake, R., Gasmi, I., Dehaye, J., Lardinois, F., Peiffer, R., Maloujahmoum, N., Agirman, F., KOOPMANSCH, B., D’Haene, N., Azurmendi Senar, O., Arsenijevic, T., Lambert, F., Peulen, O., Van Laethem, J.-L., & Bellahcene, A. (17 May 2023). Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response. Cells, 12 (10), 1414. doi:10.3390/cells12101414
Peer Reviewed verified by ORBi

LETE, C., FERNANDEZ CARAZO, R., MENTEN, C., BECKERS, P., KOOPMANSCH, B., FRANKE, S., DE PRIJCK, B., JAMAR, M., LAMBERT, F., & BOURS, V. (July 2021). A case of early-T-cell precursor acute lymphoblastic leukemia with e6a2 BCR-ABL1 fusion transcript [Poster presentation]. 13th European Cytogenomics Conference.

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., KOOPMANSCH, B., MacKay, G. M., Chiavarina, B., Costanza, B., Rademaker, G., Durieux, F., Agirman, F., Maloujahmoum, N., Cusumano, P. G., LOVINFOSSE, P., Leung, H. Y., LAMBERT, F., Bours, V., ... Bellahcene, A. (04 February 2020). Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab. Cell Reports, 30 (5), 1400-1416.e6. doi:10.1016/j.celrep.2020.01.012
Peer Reviewed verified by ORBi

FERNANDEZ CARAZO, R., KOOPMANSCH, B., PALMEIRA, L., CHARLOTEAUX, B., & LAMBERT, F. (2020). Hematopoietic Malignancies with Germline Predisposition Diagnosis with Filtered Whole Exome Sequencing and in silico Panel Analysis [Poster presentation]. European School of Haematology 2020.

DELPORTE, G., Delcorde, I., RORIVE, A., JEUGMANS, A.-M., MOONEN, M., KOOPMANSCH, B., Moonen, G., & Delvenne, P. (2020). Cas clinique. Maladie d’Erdheim-Chester. Revue Médicale de Liège, 75 (4), 213-217.

LOVINFOSSE, P., POLUS, M., VAN DAELE, D., Martinive, P., DAENEN, F., Hatt, M., Visvikis, D., KOOPMANSCH, B., LAMBERT, F., COIMBRA MARQUES, C., SEIDEL, L., Albert, A., Delvenne, P., & Hustinx, R. (2018). FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-017-3855-5
Peer Reviewed verified by ORBi

Costanza, B., Turtoi, A., Bellahcene, A., Hirano, T., Peulen, O., Blomme, A., Hennequiere, J., MUTIJIMA NZARAMBA, E., Boniver, J., Meuwis, M.-A., JOSSE, C., KOOPMANSCH, B., SEGERS, K., Yokobori, T., Fahmy, K., Thiry, M., COIMBRA MARQUES, C., Garbacki, N., Colige, A., ... Castronovo, V. (2018). Innovative methodology for the identification of soluble biomarkers in fresh tissues. Oncotarget, 9 (12), 10665-10680. doi:10.18632/oncotarget.24366
Peer Reviewed verified by ORBi

Herfs, M., RONCARATI, P., KOOPMANSCH, B., Peulen, O., Bruyère, D., Lebeau, A., Hendrick, E., Hubert, P., PONCIN, A., Penny, W., Piazzon, N., Monnien, F., Guenat, D., Mougin, C., Prétet, J.-L., Vuitton, L., SEGERS, K., LAMBERT, F., BOURS, V., ... Delvenne, P. (2018). A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalized medicine. British Journal of Cancer, 118(10), 1302-1312. doi:10.1038/s41416-018-0049-2
Peer Reviewed verified by ORBi

SAGOT, C., CHARLIER, H., KOOPMANSCH, B., & LAMBERT, F. (29 January 2016). Two cases of atypical CALR mutations in MPN patients [Poster presentation]. BHS General annual meeting 2016.

KOOPMANSCH, B., LOPEZ Y CADENAS, M., Hennuy, B., & LAMBERT, F. (29 January 2016). Identification of a TPM3-PDGFRB fusion transcript and its chromosomal breakpoints by RNA-Seq in a case of Chronic Eosinophilic Leukemia [Poster presentation]. BHS General Annual Meeting 2016, United States - Texas.

LOVINFOSSE, P., KOOPMANSCH, B., LAMBERT, F., JODOGNE, S., KUSTERMANS, G., Hatt, M., Visvikis, D., SEIDEL, L., POLUS, M., Albert, A., DELVENNE, P., & HUSTINX, R. (2016). 18F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status. British Journal of Radiology, 20160212. doi:10.1259/bjr.20160212
Peer Reviewed verified by ORBi

DIDEBERG, V., SEGERS, K., KOOPMANSCH, B., LAMBERT, F., & Bours, V. (2015). PHARMACOGENOMIQUE ET MEDECINE PERSONNALISEE : VERS UN SCREENING SYSTEMATIQUE DE LA POPULATION ? Revue Médicale de Liège, 70 (5-6), 251-6.

JERUSALEM, G., COLLIGNON, J., Josse, C., SCHROEDER, H., RORIVE, A., FRERES, P., LAMBERT, F., KOOPMANSCH, B., PONCIN, A., & BOURS, V. (2015). Cancer du sein : de la thérapie ciblée à la médecine personnalisée. Revue Médicale de Liège, 70 (5-6), 269-276.
Peer reviewed

Koopmansch, B. (2013). Contribution à l'étude des mécanismes transcriptionnels du facteur de transcription SIP1/ZEB2 [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/145015

Koopmansch, B., Berx, G., Foidart, J.-M., Gilles, C., & Winkler, R. (22 February 2013). Interplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expression. Biochemical and Biophysical Research Communications, 431 (4), 652. doi:10.1016/j.bbrc.2013.01.070
Peer reviewed

Koopmansch, B. (18 April 2012). Interactions of KLF4 and SIP1 in the regulation of E-Cadherin expression [Poster presentation]. Biomedica 2012.

Koopmansch, B. (19 May 2011). dentification of SIP1-modulated genes during the epithelial-to-mesenchymal transition and interactions with KLF factors in EMT control [Poster presentation]. GIGA-Cancer Day.

Nolens, G., Pignon, J.-C., Koopmansch, B., Elmoualij, B., Zorzi, W., De Pauw, E., & Winkler, R. (11 November 2009). Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines. Breast Cancer Research, 11 (6). doi:10.1186/bcr2450
Peer Reviewed verified by ORBi

Pignon, J.-C., Koopmansch, B., Nolens, G., Delacroix, L., Waltregny, D., & Winkler, R. (01 April 2009). Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines. Cancer Research, 69 (7), 2941-2949. doi:10.1158/0008-5472.CAN-08-3760
Peer Reviewed verified by ORBi

Contact ORBi